David Shaw’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-74,700
Closed -$209K 4907
2025
Q4
$209K Hold
74,700
﹤0.01% 4314
2025
Q3
$359K Buy
+74,700
New +$475K ﹤0.01% 4025
2018
Q4
Sell
-20,000
Closed -$330K 3927
2018
Q3
$330K Sell
20,000
-63,500
-76% -$1.08M ﹤0.01% 3318
2018
Q2
$1.4M Sell
83,500
-122,100
-59% -$1.98M ﹤0.01% 2478
2018
Q1
$3.2M Buy
205,600
+111,700
+119% +$1.99M ﹤0.01% 1709
2017
Q4
$1.77M Buy
+93,900
New +$2.08M ﹤0.01% 2223

Other funds holding ACH

David Shaw's ACH Position: Q2 2026 in Review

David Shaw reduced its Accendra Health (ACH) stake by 7% in Q2 2026, selling an estimated $716K and leaving 3,081,407 shares worth $10.5M. The position accounts for 0.01% of the portfolio, ranked #1766.

David Shaw first reported a position in ACH in Q3 2013 and has held it in 50 quarters since. The position peaked at $88.7M in Q2 2021. 138 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • David Shaw held 3,081,407 shares of Accendra Health worth $10.5M as of Q2 2026.
  • David Shaw sold 230,194 Accendra Health shares in Q2 2026, an estimated $716K.
  • Accendra Health made up 0.01% of David Shaw's portfolio in Q2 2026, its #1766 holding.
  • David Shaw first reported a position in Accendra Health in Q3 2013 and has held it in 50 quarters since.
  • David Shaw's Accendra Health position peaked at $88.7M in Q2 2021.
  • 138 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.